Advertisement

Topics

DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V. Company Profile

02:15 EST 10th December 2018 | BioPortfolio

The DECHEMA (Society for Chemical Engineering and Biotechnology) is a non-profit making scientific and technical society based in Frankfurt on Main. It was founded in 1926. Nowadays it has over 5000 private and institutional members. Our aim is to promote research and technical advances in the areas of chemical engineering, biotechnology and environmental protection.Our work is interdisciplinary, with scientists, engineers, and technologists working together under one roof. Experts from science, business, and government departments cooperate in working parties and subject divisions.

Location

Theodor-Heuss-Allee 25
Frankfurt am Main
60486
Germany

Contact

Phone: 0049 69 / 75 64-0
Fax: 0049 69 / 75 64-201


News Articles [119 Associated News Articles listed on BioPortfolio]

HT-SAAE stellt auf SNEC Halbzellen-Module mit PERC-Technik zur Schau

HT-SAAE hat als Reaktion auf die Marktnachfrage nach hocheffizienten Modulen seine populäre PERC-Technik aufgewertet und treibt die weltweite Kommerzialisierung voran. Das p-Typ Halbzellen-Modul m...

Paving The Runway: UTC Aerospace Systems And Lufthansa Technik Sign Component Service Agreement

CHARLOTTE, N.C., Nov. 7, 2018 /PRNewswire/ -- UTC Aerospace Systems, a unit of United Technologies Corp. (NYSE: UTX), and Lufthansa Technik AG today announced a Read more...

Jennewein Biotechnologie to Build New R&D Centre

Jennewein Biotechnologie announced the signing of a long-term lease for a 1000-m2 plot of land in Bonn Bad Godesberg, Germany, which is planned to be the site of a new R&D center for microbiome re...

Neue Details zu Apple-Autoprojekt ans Licht gekommen: Dass Apple an Technik für selbstfahrende Autos ...

Dass Apple an Technik für selbstfahrende Autos arbeitet, ist bekannt. Details hält der Konzern jedoch geheim. Jetzt gibt eine FBI-Untersuchung gegen einen Ex-Mitarbeiter Einblicke in die Dimension ....

Rentschler Biotechnologie: Klaus B. Schoepe

In this episode of PharmaTelevision News Review, Fintan Walton talks to Klaus B. Schoepe, Senior Vice President Client Relations at Rentschler Biotechnologie

WIEDERERWECKT: VIPs leisten Stanley Tucci Gesellschaft bei einem exklusiven ...

LONDON, October 26, 2018 /PRNewswire/ -- Gestern leisteten VIP-Gäste dem renommierten Schauspieler, Schriftsteller, Regisseur und Produzenten Stanley Tucci Gesellschaft, als Johnnie Walker die Enthü...

Trading-Idee Biogen: Beachtenswertes Biotechnologie-Unternehmen

Biogen ist ein beachtenswertes Biotechnologie-Unternehmen. Daher kommt man im Bereich der Neurowissenschaften um Biogen nicht herum. Insbesondere mit seiner Spezialisierung auf Erkrankungen der Ner...

Jennewein Biotechnologie to build new R&D centre in Bonn, Germany

Jennewein Biotechnologie announces that on June 15, 2018, it signed a long-term lease for a 1000-m2 plot of land on Mildred-Scheel-Straße, Bonn Bad Godesberg, which will be the site of a new R&D cent...

Drugs and Medications [1 Associated Drugs and Medications listed on BioPortfolio]

Firmagon [Ferring Pharmaceuticals Inc.]

These highlights do not include all the information needed to use FIRMAGON safely and effectively. See full prescribing information for FIRMAGON. FIRMAGON® (degarelix for injection) for subcutaneous ...

Clinical Trials [5 Associated Clinical Trials listed on BioPortfolio]

A Study of the Current Medical Practice and Outcomes in the Treatment of Type 2 Diabetes Mellitus in an Office Setting (MK-0431-199)

The purpose of this study is to collect information of the risk profile of patients with type 2 diabetes mellitus, their treatment concerning meeting the guidelines for treatment of diabet...

Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)Opsoclonus Myoclonus Syndrome/Dancing Eye Syndrome (OMS/DES) in Children With and Without Neuroblastoma (NBpos and NBneg)

The OMS/DES study is a multinational European Trial for Children with the Opsoclonus Myoclonus Syndrome / Dancing Eye Syndrome. This trial brought on the way by specialists of the EPNS (E...

Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders

To investigate and compare the efficacy, safety and tolerability of ziprasidone versus placebo in the treatment of conduct disorder (CD), oppositional defiant disorder (ODD) and disruptive...

Effects of Empagliflozin Plus Linagliptin vs Metformin Plus Insulin Glargin on Renal and Vascular Changes in Type 2 Diabetes

Diabetes mellitus is a wide-spread disease accompanied by strongly increased morbidity and mortality due to micro- and macrovascular complications. However, in studies with patients suffer...

Youth FORWARD Phase 1 YRI and EPP Study

Objectives: The objectives of this research proposal are to study the delivery of an evidence-based mental health intervention in the alternate setting of youth employment programs tied to...

Companies [42 Associated Companies listed on BioPortfolio]

DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V.

The DECHEMA (Society for Chemical Engineering and Biotechnology) is a non-profit making scientific and technical society based in Frankfurt on Main. It was founded in 1926. Nowadays it has over 5000 p...

IG Instrumenten-Gesellschaft AG

Innovativ und fundiert Qualität hat bei IG Tradition. IG vertritt ausschliesslich führende Hersteller von Laborgeräten, Labor-Reagenzien, Labor-Verbrauchsmaterial und Diagnostika.Ob in der Krebs- o...

ICHTHYOL-GESELLSCHAFT

ICHTHYOL-GESELLSCHAFT, our independent, family-run pharmaceutical company became one of the most important suppliers of therapeutics in dermatology and orthopedics due to active ingredients of high gr...

Centre québécois d'innovation en biotechnologie

Le Centre québécois d'innovation en biotechnologie (CQIB), un organisme privé sans but lucratif fondé en 1995, est un incubateur d'entreprises spécialisé en biotechnologie. Accompagner, Innover,...

Vereinigung deutscher Biotechnologie-Unternehmen

VBU was founded in October 1996 by 55 German biotechnology companies. It is part of DECHEMA, Germany´s largest non profit organization in biotechnology. By January 2004, the number of VBU member comp...

More Information about "DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V." on BioPortfolio

We have published hundreds of DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V. news stories on BioPortfolio along with dozens of DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V. Clinical Trials and PubMed Articles about DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V. Companies in our database. You can also find out about relevant DECHEMA Gesellschaft fürChemische Technik und Biotechnologie e.V. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...


Corporate Database Quicklinks



Searches Linking to this Company Record